newsfilter
← Latest News
GlobeNewswire·

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouthNo FDA-approved therapy currently exists for OLPPatient registry and OLP study information is now